OMNIAB, INC. Increase (Decrease) in Prepaid Expense and Other Assets
OMNIAB, INC. (OABI) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$236.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $276.00K.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$512.00K, a 801.37% decline year-over-year.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $787.00K.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $457.00K, a 14.42% decline year-over-year.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.11M.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$642.00K.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.32M, a 149.24% decline from fiscal 2022.
- OMNIAB, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $4.71M, a 645.89% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$236.00K 10-Q · filed 2026-08-06 | $551.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.01M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$512.00K 10-Q · filed 2026-05-07 | $275.00K derived: sum of 2 quarters · filed 2026-05-07 | $732.00K derived: sum of 3 quarters · filed 2026-05-07 | $524.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $1.24M derived: sum of 2 quarters · filed 2026-03-04 | $1.04M derived: sum of 3 quarters · filed 2026-08-06 | $1.11M 10-K · filed 2026-03-04 |
| 2025-09-30 | $457.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $249.00K derived: sum of 2 quarters · filed 2026-08-06 | $322.00K 10-Q · filed 2025-11-04 | $21.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$135.00K 10-Q · filed 2026-08-06 | -$436.00K derived: sum of 3 quarters · filed 2026-08-06 | $98.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $73.00K 10-Q · filed 2026-05-07 | -$228.00K derived: sum of 2 quarters · filed 2026-05-07 | $306.00K derived: sum of 3 quarters · filed 2026-05-07 | -$160.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $233.00K derived: sum of 2 quarters · filed 2026-03-04 | -$233.00K derived: sum of 3 quarters · filed 2026-03-04 | -$642.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $68.00K derived: sum of 2 quarters · filed 2025-11-04 | -$341.00K 10-Q · filed 2025-11-04 | -$350.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$466.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$875.00K 10-Q · filed 2025-08-06 | -$884.00K derived: sum of 3 quarters · filed 2025-08-06 | -$977.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$409.00K 10-Q · filed 2025-05-08 | -$418.00K derived: sum of 2 quarters · filed 2025-05-08 | -$511.00K derived: sum of 3 quarters · filed 2025-05-08 | -$1.94M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$102.00K derived: sum of 2 quarters · filed 2025-03-18 | -$1.53M derived: sum of 3 quarters · filed 2025-03-18 | -$2.32M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.52M derived: sum of 2 quarters · filed 2024-11-12 | -$2.31M 10-Q · filed 2024-11-12 | $1.58M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.22M 10-Q · filed 2024-08-08 | $1.68M derived: sum of 3 quarters · filed 2024-08-08 | $2.13M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$789.00K 10-Q · filed 2024-05-09 | $3.11M derived: sum of 2 quarters · filed 2024-05-09 | $3.56M derived: sum of 3 quarters · filed 2024-05-09 | $3.51M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $4.35M derived: sum of 2 quarters · filed 2024-03-25 | $4.30M derived: sum of 3 quarters · filed 2024-03-25 | $4.71M 10-K · filed 2024-03-25 |
| 2022-09-30 | $452.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $400.00K derived: sum of 2 quarters · filed 2023-11-09 | $817.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $365.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $417.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $632.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |